Cutler Group’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-4,500
Closed -$11K 2175
2023
Q4
$11K Hold
4,500
﹤0.01% 2311
2023
Q3
$9K Hold
4,500
﹤0.01% 2502
2023
Q2
$10K Hold
4,500
﹤0.01% 2228
2023
Q1
$13K Hold
4,500
﹤0.01% 2138
2022
Q4
$10K Sell
4,500
-252
-5% -$603 ﹤0.01% 2673
2022
Q3
$9K Sell
4,752
-406
-8% -$956 ﹤0.01% 3170
2022
Q2
$13K Sell
5,158
-42
-0.8% -$107 ﹤0.01% 2989
2022
Q1
$15K Sell
5,200
-18,504
-78% -$56.6K ﹤0.01% 3260
2021
Q4
$92K Buy
23,704
+17,504
+282% +$68K ﹤0.01% 1911
2021
Q3
$26K Buy
6,200
+1,000
+19% +$3.33K ﹤0.01% 3094
2021
Q2
$15K Hold
5,200
﹤0.01% 3527
2021
Q1
$17K Hold
5,200
﹤0.01% 3327
2020
Q4
$18K Hold
5,200
﹤0.01% 2740
2020
Q3
$16K Buy
+5,200
New +$15.8K ﹤0.01% 2612
2019
Q2
Sell
-3,600
Closed -$12K 4131
2019
Q1
$12K Buy
3,600
+3,000
+500% +$11.5K ﹤0.01% 2363
2018
Q4
$2K Buy
+600
New +$2.96K ﹤0.01% 3307
2018
Q3
Sell
-500
Closed -$4.96K 4013
2018
Q2
$3K Hold
500
﹤0.01% 3337
2018
Q1
$2K Sell
500
-3,200
-86% -$16.9K ﹤0.01% 3701
2017
Q4
$18K Buy
3,700
+2,300
+164% +$13.5K ﹤0.01% 2628
2017
Q3
$8K Sell
1,400
-400
-22% -$1.71K ﹤0.01% 3957
2017
Q2
$6K Sell
1,800
-26,951
-94% -$92.7K ﹤0.01% 4621
2017
Q1
$93K Buy
28,751
+17,287
+151% +$48K ﹤0.01% 1807
2016
Q4
$28K Buy
11,464
+1,784
+18% +$5.19K ﹤0.01% 3107
2016
Q3
$33K Sell
9,680
-1,100
-10% -$4.3K ﹤0.01% 2886
2016
Q2
$37K Sell
10,780
-1,300
-11% -$5.5K ﹤0.01% 2667
2016
Q1
$49K Buy
12,080
+7,500
+164% +$26.8K ﹤0.01% 2344
2015
Q4
$20K Buy
+4,580
New +$25.1K ﹤0.01% 3403

Other funds holding ABUS